Malaysian Genomics Resource Centre Berhad 過去の業績

過去基準チェック /06

Malaysian Genomics Resource Centre Berhadの収益は年間平均-17.9%の割合で減少していますが、 Life Sciences業界の収益は年間増加しています。収益は年間20.1% 33.4%割合で増加しています。

主要情報

-17.9%

収益成長率

-11.3%

EPS成長率

Life Sciences 業界の成長	26.8%
収益成長率	33.4%
株主資本利益率	-50.8%
ネット・マージン	-81.1%
前回の決算情報	30 Jun 2024

Recent updates

Is Now An Opportune Moment To Examine Malaysian Genomics Resource Centre Berhad (KLSE:MGRC)?

Mar 02

We Think Malaysian Genomics Resource Centre Berhad (KLSE:MGRC) Can Afford To Drive Business Growth

Feb 15

Companies Like Malaysian Genomics Resource Centre Berhad (KLSE:MGRC) Are In A Position To Invest In Growth

Nov 02

収支内訳

Malaysian Genomics Resource Centre Berhad の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。

収益と収入の歴史

KLSE:MGRC 収益、費用、利益 ( )MYR Millions
日付	収益	収益	G+A経費
30 Jun 24	10	-8	15
31 Mar 24	11	-18	25
31 Dec 23	10	-19	26
30 Jun 23	8	-14	19
31 Mar 23	12	1	10
31 Dec 22	17	6	9
30 Sep 22	23	8	8
30 Jun 22	28	7	8
31 Mar 22	22	1	7
31 Dec 21	19	-1	6
30 Sep 21	11	-3	6
30 Jun 21	2	-4	6
31 Mar 21	-3	-31	6
31 Dec 20	-4	-33	7
30 Sep 20	1	-7	7
30 Jun 20	1	-6	7
31 Mar 20	5	20	6
31 Dec 19	5	21	5
30 Sep 19	0	-5	4
30 Jun 19	0	-5	5
31 Mar 19	7	-4	6
31 Dec 18	13	-5	9
30 Sep 18	20	-5	11
30 Jun 18	26	-5	13
31 Mar 18	23	-3	13
31 Dec 17	18	-1	11
30 Sep 17	13	-1	10
30 Jun 17	10	1	8
31 Mar 17	9	0	7
31 Dec 16	9	1	7
30 Sep 16	10	2	7
30 Jun 16	10	2	7
31 Mar 16	12	2	8
31 Dec 15	14	3	9
30 Sep 15	15	4	9
30 Jun 15	14	4	9
31 Mar 15	13	3	9
31 Dec 14	9	0	9
30 Sep 14	6	-2	9
30 Jun 14	4	-4	9
31 Mar 14	3	-6	8
31 Dec 13	2	-6	8

質の高い収益: MGRCは現在利益が出ていません。

利益率の向上: MGRCは現在利益が出ていません。

フリー・キャッシュフローと収益の比較

過去の収益成長分析

収益動向: MGRCは利益が出ておらず、過去 5 年間で損失は年間17.9%の割合で増加しています。

成長の加速: MGRCの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: MGRCは利益が出ていないため、過去 1 年間の収益成長をLife Sciences業界 ( -3.9% ) と比較することは困難です。

株主資本利益率

高いROE: MGRCは現在利益が出ていないため、自己資本利益率 ( -50.78% ) はマイナスです。

Malaysian Genomics Resource Centre Berhad 過去の業績

過去 基準チェック /06

主要情報

最近の業績更新

Full year 2023 earnings: EPS and revenues miss analyst expectations

Full year 2023 earnings released: RM0.11 loss per share (vs RM0.059 profit in FY 2022)

Third quarter 2023 earnings released: RM0.022 loss per share (vs RM0.016 profit in 3Q 2022)

Second quarter 2023 earnings released: RM0.01 loss per share (vs RM0.008 profit in 2Q 2022)

First quarter 2023 earnings released: EPS: RM0.007 (vs RM0.002 in 1Q 2022)

Full year 2022 earnings released: EPS: RM0.059 (vs RM0.04 loss in FY 2021)

Recent updates

New major risk - Market cap size

Malaysian Genomics Resource Centre Berhad Appoints Yap Kok Wei as Independent and Non Executive Director

New major risk - Revenue and earnings growth

Malaysian Genomics Resource Centre Berhad, Annual General Meeting, Apr 29, 2024

Malaysian Genomics Resource Centre Berhad, Annual General Meeting, Apr 29, 2024

Malaysian Genomics Resource Centre Berhad Announces Redesignation of Encik Muhammad Badri Bin Hussin to Chief Operating Officer from Director

Full year 2023 earnings: EPS and revenues miss analyst expectations

Malaysian Genomics Resource Centre Berhad Announces Update on Material Litigation

Malaysian Genomics Resource Centre Berhad Appoints Mohammad Hasni Bin Ibrahim as Independent and Non Executive Director

Malaysian Genomics Resource Centre Berhad Appoints Datuk Wira Muhammad Faizal Bin Zainol as Independent and Non Executive Director

Malaysian Genomics Resource Centre Berhad Announces Re-Designation of Aswath A/L Ramakrishnan as A Non-Audit and Risk Management Committee Member

Malaysian Genomics Resource Centre Berhad Provides Material Litigation Update

Malaysian Genomics Resource Centre Berhad Appoints Encik Muhammad Badri Bin Hussin, Age 50, as Member of Audit Committee, Date of Change 25 Oct 2023

Malaysian Genomics Resource Centre Berhad Announces Appointment of Encik Muhammad Badri Bin Hussin as Independent and Non Executive Director

Malaysian Genomics Resource Centre Berhad Announces Appointment of Encik Mohamad Ruzaini Bin Hamzah as Independent and Non Executive Director

Malaysian Genomics Resource Centre Berhad Announces Resignation of Encik Sasha Omar Firdaus Bin Aamir Nordin as Chief Executive Officer

Full year 2023 earnings released: RM0.11 loss per share (vs RM0.059 profit in FY 2022)

Malaysian Genomics Resource Centre Berhad Announces Resignation of Aswath A/L Ramakrishnan as Independent and Non Executive Member of Nomination and Remuneration Committee

High number of new and inexperienced directors

Malaysian Genomics Resource Centre Berhad Appoints Miss Chih Yi May as Independent and Non Executive Director effective June 1, 2023

High number of new and inexperienced directors

Consensus revenue estimates fall by 33%

Malaysian Genomics Resource Centre Berhad Appoints Encik Syed Zulkifli Bin Syed Ismail as Independent and Non Executive Member of Nomination and Remuneration Committee

Third quarter 2023 earnings released: RM0.022 loss per share (vs RM0.016 profit in 3Q 2022)

Malaysian Genomics Resource Centre Berhad Re-designates Encik Mohd Shakir Bin Shahimi to Chairman of Audit Committee

Malaysian Genomics Resource Centre Berhad Appoints Mr. Aswath A/L Ramakrishnan as Independent and Non Executive Director

Is Now An Opportune Moment To Examine Malaysian Genomics Resource Centre Berhad (KLSE:MGRC)?

Price target decreased by 13% to RM0.95

Second quarter 2023 earnings released: RM0.01 loss per share (vs RM0.008 profit in 2Q 2022)

First quarter 2023 earnings released: EPS: RM0.007 (vs RM0.002 in 1Q 2022)

Malaysian Genomics Resource Centre Berhad Announces the Re-Designation of Encik Mohd Shakir Bin Shahimi from Member of Nomination and Remuneration Committee to Chairman of Nomination and Remuneration Committee

High number of new and inexperienced directors

Malaysian Genomics Resource Centre Berhad Announces Resignation of Teoh Ai Ling as Principal Officer

Full year 2022 earnings released: EPS: RM0.059 (vs RM0.04 loss in FY 2021)

High number of new and inexperienced directors

Full year 2022 earnings released: EPS: RM0.059 (vs RM0.04 loss in FY 2021)

Malaysian Genomics Resource Centre Berhad Appoints Encik Mohd Shakir Bin Shahimi as Member of Nomination and Remuneration Committee

High number of new and inexperienced directors

Malaysian Genomics Resource Centre Berhad announces redesignation of Dato' Seri Dr. Chen Chaw Min from Independent Director to Independent and Non Executive Chairman

Others Malaysian Genomics Announces Board Changes

Malaysian Genomics Resource Centre Berhad Appoints Ku Chong Hong, Designation Chairman of Nomination and Remuneration Committee Directorate Independent and Non Executive, Date of Change 13 Jul 2022

Third quarter 2022 earnings released: EPS: RM0.016 (vs RM0.002 in 3Q 2021)

High number of new and inexperienced directors

Malaysian Genomics Resource Centre Berhad Announces the Launch of Its Genetic Screening Plus Personalised Health Supplements Solutions on the Airasia Super App

Second quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Malaysian Genomics Resource Centre Berhad Announces Re-Designation of Encik Noor Azri Bin Dato' Sri Noor Azerai as Independent Executive Director

We Think Malaysian Genomics Resource Centre Berhad (KLSE:MGRC) Can Afford To Drive Business Growth

High number of new and inexperienced directors

First quarter 2022 earnings: EPS in line with expectations, revenues disappoint

High number of new directors

Financial Controller Sek Cheah has left the company

Senior Independent Non-Executive Chairman Rafiah Salim has left the company

Companies Like Malaysian Genomics Resource Centre Berhad (KLSE:MGRC) Are In A Position To Invest In Growth

Full year 2021 earnings released: RM0.04 loss per share (vs RM0.062 loss in FY 2020)

High number of new directors

New 90-day high: RM1.22

New 90-day high: RM1.18

New 90-day high: RM1.11

New 90-day high: RM0.80

Malaysian Genomics Resource Centre Berhad Renames the Audit Committee as Audit and Risk Management Committee

First quarter 2021 earnings released: RM0.008 loss per share

New 90-day high: RM0.64

Malaysian Genomics Resource Centre Berhad Announces Appointment of ENCIK SASHA OMAR FIRDAUS BIN AAMIR NORDIN as Chief Executive Officer

New 90-day high - RM0.53

Malaysian Genomics Resource Centre Berhad Announces Resignation of Encik Robert George Hercus @ Abdul Karim Hercus as Executive Managing Director

収支内訳

収益と収入の歴史

フリー・キャッシュフローと収益の比較

過去の収益成長分析

過去基準チェック /06